News | June 10, 2009

TUG Procedure Can Reduce or Eliminate Need for X-Rays in the Cath Lab

June 10, 2009 - Interventional cardiac catheterization procedures are one of the most effective treatments for peripheral vascular disease (PVD), but the procedures are not an option for millions with PVD who also have kidney problems or allergies to the contrast dye used during the procedures.

As a possible new option for these patients, Tony Das, M.D., an interventional cardiologist at Texas Health Presbyterian Hospital Dallas, recently demonstrated a unique procedure that clears femoral artery blockages without the use of contrast dye or X-ray radiation.

"We're always looking for new and innovative ways to better care for patients with this debilitating condition," Dr. Das said. "This procedure could one day be something we offer people who are not suitable candidates for other interventional procedures."

Called TUG (transcutaneous ultrasound guided vascular intervention), the procedure involves using an ultrasound device on top of the patient's skin to produce images of the arteries to navigate the guide wire and stent the artery.

"With the prevalence of diabetes and obesity among an already aging population, the challenges facing those involved in the diagnosis and treatment of peripheral vascular disease increase by the minute," Dr. Das said. "It's a problem that will increasingly challenge medical experts around the country in coming years."

PVD is a common condition affecting more than 10 million adults in the United States. The condition is a disease of blood vessels outside the heart and brain characterized by a narrowing of vessels that carry blood to the legs, arms, stomach and kidneys. The condition causes lower-leg tissue damage, non-healing wounds, blood clots and limb loss.

"Currently, PVD patients with kidney problems or allergies to contrast dye can only be treated with medications or open surgery, which carries a higher risk for complications," said Jon Gardner, administrative director of the heart and vascular service line at Texas Health Dallas. "Innovative new procedures like Dr. Das' technique could provide hope to these patients."

For more information: www.texashealth.org/


Related Content

News | Cardiovascular Ultrasound

Septe. 30, 2025 -- GE HealthCare Vivid iq Ultrasound system has been selected by NASA for delivery to the International ...

Home October 09, 2025
Home
News | Cardiovascular Ultrasound

Sept. 26, 2025 — A new guideline from the American Society of Echocardiography (ASE) offers updated and expanded ...

Home October 03, 2025
Home
News | Cardiovascular Ultrasound

Aug. 27, 2025 — Royal Philips has released Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx ...

Home August 27, 2025
Home
News | Cardiovascular Ultrasound

Aug. 14, 2025 — Philips has announced a plan for new investments of more than $150 million in U.S. manufacturing and ...

Home August 14, 2025
Home
News | Cardiovascular Ultrasound

March 24, 2025 — FUJIFILM Healthcare Americas Corp. and Us2.ai have partnered to equip Fujifilm’s LISENDO 800 ...

Home March 24, 2025
Home
News | Cardiovascular Ultrasound

Feb. 11, 2025 — UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound ...

Home February 18, 2025
Home
News | Cardiovascular Ultrasound

May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...

Home May 30, 2024
Home
News | Cardiovascular Ultrasound

April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...

Home April 05, 2024
Home
News | Cardiovascular Ultrasound

August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...

Home August 24, 2023
Home
News | Cardiovascular Ultrasound

July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...

Home July 27, 2023
Home
Subscribe Now